Cargando…
LncRNA UCA1 in anti-cancer drug resistance
The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression of lncRNA UCA1 correlates with resistance to chemotherapeutics such as cisplatin, gemcitabine, 5-FU, tamoxifen, imatinib and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610032/ https://www.ncbi.nlm.nih.gov/pubmed/28969100 http://dx.doi.org/10.18632/oncotarget.18344 |
_version_ | 1783265715461029888 |
---|---|
author | Wang, Haohao Guan, Zhonghai He, Kuifeng Qian, Jiong Cao, Jiang Teng, Lisong |
author_facet | Wang, Haohao Guan, Zhonghai He, Kuifeng Qian, Jiong Cao, Jiang Teng, Lisong |
author_sort | Wang, Haohao |
collection | PubMed |
description | The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression of lncRNA UCA1 correlates with resistance to chemotherapeutics such as cisplatin, gemcitabine, 5-FU, tamoxifen, imatinib and EGFR-TKIs, whereas lncRNA UCA1 knockdown restores drug sensitivity. These studies highlight the potential of lncRNA UCA1 as a diagnostic and prognostic biomarker, and a therapeutic target in malignant tumors. In this review, we address the role of lncRNA UCA1 in anti-cancer drug resistance and discuss its potential in future clinical applications. |
format | Online Article Text |
id | pubmed-5610032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56100322017-09-29 LncRNA UCA1 in anti-cancer drug resistance Wang, Haohao Guan, Zhonghai He, Kuifeng Qian, Jiong Cao, Jiang Teng, Lisong Oncotarget Review The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression of lncRNA UCA1 correlates with resistance to chemotherapeutics such as cisplatin, gemcitabine, 5-FU, tamoxifen, imatinib and EGFR-TKIs, whereas lncRNA UCA1 knockdown restores drug sensitivity. These studies highlight the potential of lncRNA UCA1 as a diagnostic and prognostic biomarker, and a therapeutic target in malignant tumors. In this review, we address the role of lncRNA UCA1 in anti-cancer drug resistance and discuss its potential in future clinical applications. Impact Journals LLC 2017-06-02 /pmc/articles/PMC5610032/ /pubmed/28969100 http://dx.doi.org/10.18632/oncotarget.18344 Text en Copyright: © 2017 Wang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Review Wang, Haohao Guan, Zhonghai He, Kuifeng Qian, Jiong Cao, Jiang Teng, Lisong LncRNA UCA1 in anti-cancer drug resistance |
title | LncRNA UCA1 in anti-cancer drug resistance |
title_full | LncRNA UCA1 in anti-cancer drug resistance |
title_fullStr | LncRNA UCA1 in anti-cancer drug resistance |
title_full_unstemmed | LncRNA UCA1 in anti-cancer drug resistance |
title_short | LncRNA UCA1 in anti-cancer drug resistance |
title_sort | lncrna uca1 in anti-cancer drug resistance |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610032/ https://www.ncbi.nlm.nih.gov/pubmed/28969100 http://dx.doi.org/10.18632/oncotarget.18344 |
work_keys_str_mv | AT wanghaohao lncrnauca1inanticancerdrugresistance AT guanzhonghai lncrnauca1inanticancerdrugresistance AT hekuifeng lncrnauca1inanticancerdrugresistance AT qianjiong lncrnauca1inanticancerdrugresistance AT caojiang lncrnauca1inanticancerdrugresistance AT tenglisong lncrnauca1inanticancerdrugresistance |